Contribution of UDP-glucuronosyltransferases 1A9 and 2B7 to the glucuronidation of indomethacin in the human liver

European Journal of Clinical Pharmacology

Volumn 63, Issue 3, 2007, Pages 289-296

  Mano, Yuji ^a   Usui, Takashi ^a   Kamimura, Hidetaka ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Glucuronidation; Human; Indomethacin; UGT1A9; UGT2B7

Indexed keywords

GLUCURONOSYLTRANSFERASE 1A3; GLUCURONOSYLTRANSFERASE 1A9; GLUCURONOSYLTRANSFERASE 2B7; INDOMETACIN; MORPHINE; ZIDOVUDINE;

ARTICLE; CATALYSIS; CORRELATION ANALYSIS; ENZYME ACTIVITY; GLUCURONIDATION; HUMAN; HUMAN TISSUE; IC 50; INHIBITION KINETICS; ISOENZYME ANALYSIS; KINETICS; LIVER; LIVER MICROSOME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION;

GLUCURONIDES; GLUCURONOSYLTRANSFERASE; HUMANS; INDOMETHACIN; LIVER; MASS SPECTROMETRY; MORPHINE; PROPOFOL; ZIDOVUDINE;

EID: 33846932096     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-007-0261-0     Document Type: Article

References (22)

1. Vree TB, van den Biggelaar-Martea M, Verwey-van Wissen CP (1993) Determination of indomethacin, its metabolites and their glucuronides in human plasma and urine by means of direct gradient high-performance liquid chromatographic analysis. Preliminary pharmacokinetics and effect of probenecid. J Chromatogr 616:271-282
2. Hucker HB, Zacchei AG, Cox SV, Brodie DA, Cantwell NHR (1966) Studies on the absorption, distribution and excretion of indomethacin in various species. J Pharmacol Exp Ther 153:237-249
3. Duggan DE, Hogans AF, Kwan KC, McMahon FG (1972) The metabolism of indomethacin in man. J Pharmacol Exp Ther 181:563-575
4. Kwan KC, Breault GO, Umbenhauer ER, McMahon FG, Duggan DE (1976) Kinetics of indomethacin absorption, elimination, and enterohepatic circulation in man. J Pharmacokinet Biop 4:255-280
5. Van Hecken A, Verbesselt R, Tjandra-Maga TB, De Schepper PJ (1989) Pharmacokinetic interaction between indomethacin and diflunisal. Eur J Clin Pharmacol 36:507-512
6. Kuehl GE, Lampe JW, Potter JD, Bigler J (2005) Glucuronidation of nonsteroidal anti-inflammatory drugs: identifying the enzymes responsible in human liver microsomes. Drug Metab Dispos 33:1027-1035
7. Mano Y, Usui T, Kamimura H (2005) In vitro inhibitory effects of non-steroidal antiinflammatory drugs on UDP-glucuronosyltransferase 1A1-catalysed estradiol 3β-glucuronidation in human liver microsomes. Biopharm Drug Dispos 26:35-39
8. Mano Y, Usui T, Kamimura H (2006) In vitro inhibitory effects of non-steroidal antiinflammatory drugs on UDP-glucuronosyltransferase 1A9-catalysed 4-methylumbelliferone glucuronidation by recombinant human UGT1A9 - potent inhibition by niflumic acid. Biopharm Drug Dispos 27:1-6
9. Mano Y, Usui T, Kamimura H (2004) Effects of β-estradiol and propofol on the 4-methylumbelliferone glucuronidation by recombinant human UGT isozymes 1A1, 1A8 and 1A9. Biopharm Drug Dispos 25:339-344
10. Mano Y, Usui T, Kamimura H (2006) Identification of human UDP-glucuronosyltransferase responsible for the glucuronidation of niflumic acid in human liver. Pharm Res 23:1502-1508
11. Court MH, Krishnaswamy S, Hao Q, Duan SX, Patten CJ, Von Moltke LL, Greenblatt DJ (2003) Evaluation of 3′-azido-3′-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism. Drug Metab Dispos 31:1125-1133
12. Mano Y, Usui T, Kamimura H (2006) In vitro drug interaction between diflunisal and indomethacin via glucuronidation in humans. Biopharm Drug Dispos 27:267-273
13. Mano Y, Usui T, Kamimura H (2007) Inhibitory potential of nonsteroidal anti-inflammatory drugs on UDP-glucuronosyltransferase 2B7 in human liver microsomes. Eur J Clin Pharmacol (in press) DOI 10.1007/s00228-006-0241-9
14. Tukey RH, Strassburg CP (2000) Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 40:581-616
15. Burchell B, Brierley CH, Rance D (1995) Specificity of human UDP-glucuronosyltransferases and xenobiotic glucuronidation. Life Sci 57:1819-1831
16. Senafi SB, Clarke DJ, Burchell B (1994) Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation. Biochem J 303:233-240
17. de Wildt SN, Kearns GL, Leeder JS, van den Anker JN (1999) Glucuronidation in humans. Clin Pharmacokinet 36:439-452
18. Bowalgaha K, Elliot DJ, Mackenzie PI, Knights KM, Swedmark S, Miners JO (2005) S-Naproxen and desmethylnaproxen glucuronidation by human liver microsomes and recombinant human UDP-glucuronosyltransferases (UGT): role of UGT2B7 in the elimination of naproxen. Br J Clin Pharmacol 60:423-433
19. King C, Tang W, Ngui J, Tephly T, Braun M (2001) Characterization of rat and human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of diclofenac. Toxicol Sci 61:49-53
20. Tougou K, Gotou H, Ohno Y, Nakamura A (2004) Stereoselective glucuronidation and hydroxylation of etodolac by UGT1A9 and CYP2C9 in man. Xenobiotica 34:449-461
21. Ebner T, Burchell B (1993) Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of the UGT1 gene family. Drug Metab Dispos 21:50-55
22. Court MH, Duan SX, von Moltke LL, Greenblatt DJ, Patten CJ, Miners JO, Mackenzie PI (2001) Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms. J Pharmacol Exp Ther 299:998-1006